Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus H Heim

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Gut|February 5, 2017
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesisNicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, et al.
Science (New York, N.Y.)|February 22, 2014
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNAJulie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Nature Communications|December 19, 2019
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold functionFengyuan Tang, Ruize Gao, Beena Jeevan-Raj, et al.
Nature Communications|August 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically activeCelia Sequera, Margherita Grattarola, Floriane Cannet, et al.
Communications Medicine|May 23, 2022
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case reportCaner Ercan, Mairene Coto-Llerena, John Gallon, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Open Forum Infectious Diseases|November 7, 2025
Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV CoinfectionMichael J Vinikoor, Andreas Walker, Bright Nsokolo, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Nature Cell Biology|April 19, 2016
The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|December 20, 2011
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypesPierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, et al.
Gut|February 5, 2017
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesisNicolaas Van Renne, Armando Andres Roca Suarez, Francois H T Duong, et al.
Science (New York, N.Y.)|February 22, 2014
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNAJulie Lucifora, Yuchen Xia, Florian Reisinger, et al.
Nature Communications|December 19, 2019
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold functionFengyuan Tang, Ruize Gao, Beena Jeevan-Raj, et al.
Nature Communications|August 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically activeCelia Sequera, Margherita Grattarola, Floriane Cannet, et al.
Communications Medicine|May 23, 2022
Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case reportCaner Ercan, Mairene Coto-Llerena, John Gallon, et al.
Journal of Hepatology|March 15, 2012
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirinDominique Larrey, Ansgar W Lohse, Victor de Ledinghen, et al.
Open Forum Infectious Diseases|November 7, 2025
Whole-Genome Sequencing of Hepatitis B Virus Genotypes E and A in Zambia Reveals Limited Viral Diversity in HIV CoinfectionMichael J Vinikoor, Andreas Walker, Bright Nsokolo, et al.
Journal of Hepatology|June 8, 2023
Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristicsSarp Uzun, Carl P Zinner, Amke C Beenen, et al.
Nature Cell Biology|April 19, 2016
The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Pageof 15